Gradient Investments’s Editas Medicine EDIT Stock Holding History

Gradient Investments’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-250	Closed	-$7K	–	1215
2021 Q4	$7K	Hold	250	–	–	﹤0.01%	870
2021 Q3	$10K	Hold	250	–	–	﹤0.01%	771
2021 Q2	$14K	Hold	250	–	–	﹤0.01%	698
2021 Q1	$11K	Hold	250	–	–	﹤0.01%	741
2020 Q4	$7K	Hold	250	–	–	﹤0.01%	753
2020 Q3	$7K	Hold	250	–	–	﹤0.01%	759
2020 Q2	$7K	Sell	250 -185	-43%	-$4.83K	﹤0.01%	691
2020 Q1	$9K	Buy	435 +250	+135%	+$6.3K	﹤0.01%	666
2019 Q4	$5K	Sell	185 -140	-43%	-$3.5K	﹤0.01%	812
2019 Q3	$7K	Hold	325	–	–	﹤0.01%	735
2019 Q2	$8K	Buy	+325	New	+$7.76K	﹤0.01%	698
2018 Q2	–	Sell	-4	Closed	–	–	1023
2018 Q1	$0	Hold	4	–	–	﹤0.01%	1045
2017 Q4	$0	Buy	+4	New	+$101	﹤0.01%	1027

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Gradient Investments's EDIT Position: Q1 2022 in Review

Gradient Investments sold out of Editas Medicine (EDIT) in Q1 2022, closing a stake of 250 shares — an estimated $7K sold.

Gradient Investments first reported a position in EDIT in Q4 2017 and held it in 13 quarters. The position peaked at $14K in Q2 2021. 256 funds tracked by Wall St. Rank hold EDIT as of Q1 2022.

Gradient Investments reported no remaining Editas Medicine position as of Q1 2022 after selling out during the quarter.
Gradient Investments sold 250 Editas Medicine shares in Q1 2022, an estimated $7K.
Gradient Investments first reported a position in Editas Medicine in Q4 2017 and held it in 13 quarters.
Gradient Investments's Editas Medicine position peaked at $14K in Q2 2021.
256 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2022.

Based on Gradient Investments's 13F filing for Q1 2022, filed 26 May 2022.